AN OPEN LABEL PILOT STUDY OF RISPERIDONE IN TREATMEN OF METHAMPHETAMINE DEPENDENCE
Saved in:
MEREDITH, C.W., ET AL., AN OPEN LABEL PILOT STUDY OF RISPERIDONE IN TREATMEN OF METHAMPHETAMINE DEPENDENCE. JOURNAL OF PSYCHOACTIVE DRUGS, Vol. 39, no. 2 (2007), p. 167-172.
Ref.
148142
Location:
SIIS R.829 Archivo
Palabras clave:
Anfetaminas, Drogas ilegales, Drogodependencias, Experiencias, Fármacos, Tratamiento
Anfetaminas, Drogas ilegales, Drogodependencias, Experiencias, Fármacos, Tratamiento
Similar Items: AN OPEN LABEL PILOT STUDY OF RISPERIDONE IN TREATMEN OF METHAMPHETAMINE DEPENDENCE
- THE EFFECTS OF ACUTE HALOPERIDOL OR RISPERIDONE ON SUBJECTIVE RESPONSES TO METHAMPHETAMINE IN HEALTHY VOLUNTEERS
- SINGLE DOSE OF 24 MILLIGRAMS OF BUPRENORPHINE FOR HEROIN DETOXIFICATION: AN OPEN-LABEL STUDY OF FIVE INPATIENTS
- Phase 4, pilot, open-label study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for prisoners
- HEALTH RELATED QUALITY OF LIFE TRAJECTORIES OF METHAMPHETAMINE DEPENDENT INDIVIDUALS AS A FUNCTION OF TREATMEN COMPLETION AND CONTINUED CARE OVER A 1 YEAR PERIOS
- REDUCED CARDIOVASCULARA EFFECTS OF METHAMPHETAMINE FOLLOWING TREATMENT WITH SELEGILINE
- AN OPEN-LABEL STUDY OF NALTREXONE AND BUPROPION COMBINATION THERAPY FOR SMOKING CESSATION IN OVERWEIGHT AND OBESE SUBJECTS